Regulation of SRp20 exon 4 splicing
- PMID: 11072076
- DOI: 10.1016/s0167-4781(00)00233-5
Regulation of SRp20 exon 4 splicing
Abstract
SR proteins are essential splicing factors involved in the use of both constitutive and alternative exons. We previously showed that the SR proteins SRp20 and ASF/SF2 have antagonistic activities on SRp20 pre-mRNA splicing. SRp20 activates exon 4 recognition in its pre-mRNA, whereas ASF/SF2 inhibits this recognition. In experiments aimed at testing the specificity of SRp20 and ASF/SF2 for exon 4 splicing regulation, we show here that this specificity lies in the RNA binding domains of SRp20 and ASF/SF2 and not in the RS domains. Surprisingly, a deletion of 14 amino acids at the end of ASF/SF2-RBD2 converts ASF/SF2 from an inhibitor to an activator of exon 4 splicing. We found that ASF3 also inhibits exon 4 recognition, thus acting similarly to ASF/SF2, while SC35 activates a cryptic 5' splice site downstream of exon 3 and, in doing so, represses exon 4 use. In contrast, Tra2 and the SR proteins 9G8 and SRp40 do not appear to affect exon 4 splicing.
Similar articles
-
The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.EMBO J. 1997 Aug 15;16(16):5077-85. doi: 10.1093/emboj/16.16.5077. EMBO J. 1997. PMID: 9305649 Free PMC article.
-
Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.J Biol Chem. 2002 Apr 12;277(15):12579-86. doi: 10.1074/jbc.M107867200. Epub 2002 Jan 18. J Biol Chem. 2002. PMID: 11801589
-
The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.Biochem J. 2004 Jul 15;381(Pt 2):343-50. doi: 10.1042/BJ20040408. Biochem J. 2004. PMID: 15068396 Free PMC article.
-
Human papillomavirus regulation of SR proteins.Biochem Soc Trans. 2010 Aug;38(4):1116-21. doi: 10.1042/BST0381116. Biochem Soc Trans. 2010. PMID: 20659014 Review.
-
Functions of SR and Tra2 proteins in pre-mRNA splicing regulation.Proc Soc Exp Biol Med. 1999 Feb;220(2):59-63. doi: 10.1046/j.1525-1373.1999.d01-10.x. Proc Soc Exp Biol Med. 1999. PMID: 9933499 Review. No abstract available.
Cited by
-
Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIα intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.PLoS One. 2022 May 26;17(5):e0265794. doi: 10.1371/journal.pone.0265794. eCollection 2022. PLoS One. 2022. PMID: 35617303 Free PMC article.
-
Molecular basis of RNA recognition and TAP binding by the SR proteins SRp20 and 9G8.EMBO J. 2006 Nov 1;25(21):5126-37. doi: 10.1038/sj.emboj.7601385. Epub 2006 Oct 12. EMBO J. 2006. PMID: 17036044 Free PMC article.
-
Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.Genes (Basel). 2021 Jul 18;12(7):1085. doi: 10.3390/genes12071085. Genes (Basel). 2021. PMID: 34356101 Free PMC article. Review.
-
PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.Sci Rep. 2015 Sep 29;5:14548. doi: 10.1038/srep14548. Sci Rep. 2015. PMID: 26416554 Free PMC article.
-
Biological function and molecular mechanism of SRSF3 in cancer and beyond.Oncol Lett. 2022 Jan;23(1):21. doi: 10.3892/ol.2021.13139. Epub 2021 Nov 16. Oncol Lett. 2022. PMID: 34858525 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous